High CD34 positive stem cell dosage improves thrombocyte recovery in obese myeloma patients undergoing autologous stem cell transplantation

Leuk Lymphoma. 2021 Dec;62(13):3283-3287. doi: 10.1080/10428194.2021.1950707. Epub 2021 Jul 13.

Authors

Julius C Enßle¹, Sebastian Wolf¹, Ivana von Metzler¹, Sarah Weber¹, Heike Bialleck², Erhard Seifried², Hubert Serve¹, Sebastian Scheich¹, Björn Steffen¹

Affiliations

¹ Department of Hematology and Oncology, University Hospital Frankfurt, Frankfurt am Main, Germany.
² Institute for Transfusion Medicine and Immunhematology, Goethe University and German Red Cross Blood Donor Service, Frankfurt am Main, Germany.

PMID: 34254876
DOI: 10.1080/10428194.2021.1950707

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD34
Blood Platelets
Hematopoietic Stem Cell Mobilization
Hematopoietic Stem Cell Transplantation*
Humans
Multiple Myeloma* / therapy
Obesity / complications
Obesity / therapy
Transplantation, Autologous

Substances

Antigens, CD34